Close Menu
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Facebook X (Twitter) Instagram
Facebook LinkedIn
Financial Market News
Subscribe Now
  • Home
  • Markets
    • Earnings
  • Banks
    • Crypto
    • Investing
  • Business
    • Retail
  • industry
    • Finance
    • Energy
    • Real Estate
  • Politics
Financial Market News
You are at:Home»Posts Tagged "Pfizer"

Why Pfizer Stock Trounced the Market Today

By FinMar NewsOctober 1, 2025

A bullish analyst note added to the generally good sentiment on the company. Still basking in the glow of a likely advantageous deal it signed with…

Midday stock movers: Super Micro, Apple, Pfizer

By FinMar NewsOctober 7, 2024

Here are the stocks making the biggest market moves midday. Read More: Midday stock movers: Super Micro, Apple, Pfizer

FDA approves Pfizer, Moderna updated KP.2 shots

By FinMar NewsAugust 22, 2024

Pfizer COVID-19 vaccine.Courtesy: PfizerThe Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach…

Pfizer to price Covid drug Paxlovid at $1,390 per course

By FinMar NewsOctober 19, 2023

Paxlovid, Pfizer’s antiviral medication to treat the coronavirus disease, is displayed in this picture taken on Oct. 7, 2022.Wolfgang Rattay | ReutersPfizer will price a five-day…

Pfizer cuts earnings, revenue guidance as Covid sales slump

By FinMar NewsOctober 14, 2023

Pfizer CEO Albert Bourla talks during a press conference with the president of the European Commission after a visit to oversee the production of the Pfizer-BioNTech…

Pfizer stock sinks as pharma giant cuts earnings outlook on weaker COVID

By FinMar NewsOctober 14, 2023

Shares of Pfizer Inc. and other biotech drug makers fell in the extended session Friday after Pfizer slashed $9 billion in expected sales from its full-year…

Novavax Covid vaccine can still catch up to Pfizer, Moderna shots

By FinMar NewsOctober 8, 2023

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022…

Whether COVID-19 boosters get approved or not, Pfizer and Moderna have

By FinMar NewsSeptember 23, 2023

It’s likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna Inc.…

CDC endorses third Pfizer doses for high-risk adults

By FinMar NewsSeptember 14, 2023

The Centers for Disease Control and Prevention on Thursday endorsed the distribution of Pfizer and BioNTech’s Covid-19 booster shots to older Americans and other vulnerable people, including those…

Pfizer releases new data showing side effects are similar to second dose

By FinMar NewsAugust 9, 2023

A healthcare worker administers a third dose of the Pfizer-BioNTech Covid-19 vaccine at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.Hannah…

Energy News

After gutting subsidies, White House finds new ways to stifle solar

OpenAI looks to take 10% stake in AMD through AI chip deal

Climate tech entrepreneurs remain energized despite federal cutbacks

Inside the uranium plant at the center of U.S. plans to expand nuclear

Banks News

Oak Valley Community Bank Welcomes Hardip Sheena as Vice President, Branch

Northpointe Bancshares’ Steady Dividend Signals Stability in a Recovering

Banque De France, ACPR, AMF Launch Stress Test On Interconnections With

Xavier P. Loinaz, banking luminary

Real Estate News

Another Stellar MLS data share; a new look for Maine Listings

Beverly, Mass., named hottest ZIP code in the U.S. by Realtor.com

PE Firm Sells Apartments For $37.6M

Today’s Mortgage Rates – October 5, 2025: 30-Year Fixed Rate Goes Down by

© 2025 finmar.news

Type above and press Enter to search. Press Esc to cancel.

Social Media Auto Publish Powered By : XYZScripts.com
[newsletter-pack newsletter='24']